, a bio/informatics shared resource is still "open for business" - Visit the CDS website


  1. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Damstrup L, Kuwada SK, Dempsey PJ, Brown CL, Hawkey CJ, Poulsen HS, Wiley HS, Coffey RJ (1999) Br J Cancer 80(7): 1012-9
    › Primary publication · 10362109 (PubMed) · PMC2363033 (PubMed Central)
  2. Increased intestinal epithelial proliferation in metallothioneine-transforming growth factor alpha transgenic mice. Acra SA, Bulus N, Bogatcheva G, Coffey RJ, Barnard JA (1998) Regul Pept 74(2-3): 105-12
    › Primary publication · 9712170 (PubMed)
  3. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Zhang R, Averboukh L, Zhu W, Zhang H, Jo H, Dempsey PJ, Coffey RJ, Pardee AB, Liang P (1998) Mol Cell Biol 18(10): 6131-41
    › Primary publication · 9742130 (PubMed) · PMC109199 (PubMed Central)
  4. Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. Brown CL, Meise KS, Plowman GD, Coffey RJ, Dempsey PJ (1998) J Biol Chem 273(27): 17258-68
    › Primary publication · 9642297 (PubMed)
  5. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells. Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD (1998) Cancer Res 58(11): 2323-7
    › Primary publication · 9622066 (PubMed)
  6. Mob-1, a Ras target gene, is overexpressed in colorectal cancer. Zhang R, Zhang H, Zhu W, Pardee AB, Coffey RJ, Liang P (1997) Oncogene 14(13): 1607-10
    › Primary publication · 9129152 (PubMed)
  7. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN (1997) J Clin Invest 99(9): 2254-9
    › Primary publication · 9151799 (PubMed) · PMC508057 (PubMed Central)
  8. Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells. Coffey RJ, Hawkey CJ, Damstrup L, Graves-Deal R, Daniel VC, Dempsey PJ, Chinery R, Kirkland SC, DuBois RN, Jetton TL, Morrow JD (1997) Proc Natl Acad Sci U S A 94(2): 657-62
    › Primary publication · 9012840 (PubMed) · PMC19569 (PubMed Central)
  9. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. Sheng GG, Shao J, Sheng H, Hooton EB, Isakson PC, Morrow JD, Coffey RJ, DuBois RN, Beauchamp RD (1997) Gastroenterology 113(6): 1883-91
    › Primary publication · 9394727 (PubMed)
  10. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. Gangarosa LM, Sizemore N, Graves-Deal R, Oldham SM, Der CJ, Coffey RJ (1997) J Biol Chem 272(30): 18926-31
    › Primary publication · 9228072 (PubMed)